<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>43(9)</volume><submitter>Lees EA</submitter><funding>Wellcome Trust</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>During autumn/winter 2022, UK pediatricians reported an unseasonal increase in invasive group A streptococcal infections; a striking proportion presenting with pneumonia with parapneumonic effusion.&lt;h4>Methods&lt;/h4>Clinicians across the United Kingdom were requested to submit pseudonymized clinical data using a standardized report form for children (&lt;16 years) admitted between September 30, 2022 and February 17, 2023, with microbiologically confirmed group A streptococcal pneumonia with parapneumonic effusion.&lt;h4>Results&lt;/h4>From 185 cases submitted, the median patient age was 4.4 years, and 163 (88.1%) were previously healthy. Respiratory viral coinfection was detected on admission for 101/153 (66.0%) children using extended respiratory pathogen polymerase chain reaction</pubmed_abstract><journal>The Pediatric infectious disease journal</journal><pagination>841-850</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11319078</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Epidemiology and Management of Pediatric Group A Streptococcal Pneumonia With Parapneumonic Effusion: An Observational Study.</pubmed_title><pmcid>PMC11319078</pmcid><pubmed_authors>Williams TC</pubmed_authors><pubmed_authors>Sinha A</pubmed_authors><pubmed_authors>Haynes N</pubmed_authors><pubmed_authors>Fidler K</pubmed_authors><pubmed_authors>Brampton R</pubmed_authors><pubmed_authors>Gordon S</pubmed_authors><pubmed_authors>Koo S</pubmed_authors><pubmed_authors>Hoskyns L</pubmed_authors><pubmed_authors>Hatcher J</pubmed_authors><pubmed_authors>Bakar A</pubmed_authors><pubmed_authors>Blomquist P</pubmed_authors><pubmed_authors>Adesina A</pubmed_authors><pubmed_authors>Everitt L</pubmed_authors><pubmed_authors>Carveth Johnson T</pubmed_authors><pubmed_authors>Fitzgerald F</pubmed_authors><pubmed_authors>Watson G</pubmed_authors><pubmed_authors>Pillai A</pubmed_authors><pubmed_authors>Finlay J</pubmed_authors><pubmed_authors>Dixon G</pubmed_authors><pubmed_authors>Speirs L</pubmed_authors><pubmed_authors>Lyall H</pubmed_authors><pubmed_authors>Lees EA</pubmed_authors><pubmed_authors>Marlow R</pubmed_authors><pubmed_authors>Drysdale S</pubmed_authors><pubmed_authors>Pollock L</pubmed_authors><pubmed_authors>Hey A</pubmed_authors><pubmed_authors>Bernatoniene J</pubmed_authors><pubmed_authors>McMaster P</pubmed_authors><pubmed_authors>Longbottom K</pubmed_authors><pubmed_authors>Whittaker E</pubmed_authors><pubmed_authors>Oakley J</pubmed_authors><pubmed_authors>Llano M</pubmed_authors><pubmed_authors>Lamagni T</pubmed_authors><pubmed_authors>Group A Streptococcal Disease Consortium</pubmed_authors><pubmed_authors>Devesa P</pubmed_authors><pubmed_authors>Alexander N</pubmed_authors><pubmed_authors>Hayes E</pubmed_authors><pubmed_authors>Jones C</pubmed_authors><pubmed_authors>Garde A</pubmed_authors><pubmed_authors>Elghuwael I</pubmed_authors><pubmed_authors>Inwald D</pubmed_authors><pubmed_authors>Bamford A</pubmed_authors><pubmed_authors>Hull J</pubmed_authors><pubmed_authors>Ives A</pubmed_authors><pubmed_authors>Kavanagh S</pubmed_authors><pubmed_authors>Kirk N</pubmed_authors><pubmed_authors>Kent A</pubmed_authors><pubmed_authors>Kilpatrick C</pubmed_authors><pubmed_authors>Sang TC</pubmed_authors><pubmed_authors>Rutter M</pubmed_authors><pubmed_authors>Pike K</pubmed_authors><pubmed_authors>Randle E</pubmed_authors><pubmed_authors>Smith A</pubmed_authors><pubmed_authors>Mitting R</pubmed_authors><pubmed_authors>Walsh L</pubmed_authors><pubmed_authors>Riordan A</pubmed_authors><pubmed_authors>Lorenzetti G</pubmed_authors><pubmed_authors>Kuruvilla G</pubmed_authors><pubmed_authors>Bridge T</pubmed_authors><pubmed_authors>Kumar D</pubmed_authors><pubmed_authors>Kadambari S</pubmed_authors><pubmed_authors>Bowen SJ</pubmed_authors><pubmed_authors>Vergnano S</pubmed_authors><pubmed_authors>Kuek S</pubmed_authors><pubmed_authors>Hormigo I</pubmed_authors><pubmed_authors>McShane TD</pubmed_authors><pubmed_authors>Bandi S</pubmed_authors><pubmed_authors>Brugha R</pubmed_authors><pubmed_authors>Bycroft T</pubmed_authors><pubmed_authors>Farah S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Epidemiology and Management of Pediatric Group A Streptococcal Pneumonia With Parapneumonic Effusion: An Observational Study.</name><description>&lt;h4>Background&lt;/h4>During autumn/winter 2022, UK pediatricians reported an unseasonal increase in invasive group A streptococcal infections; a striking proportion presenting with pneumonia with parapneumonic effusion.&lt;h4>Methods&lt;/h4>Clinicians across the United Kingdom were requested to submit pseudonymized clinical data using a standardized report form for children (&lt;16 years) admitted between September 30, 2022 and February 17, 2023, with microbiologically confirmed group A streptococcal pneumonia with parapneumonic effusion.&lt;h4>Results&lt;/h4>From 185 cases submitted, the median patient age was 4.4 years, and 163 (88.1%) were previously healthy. Respiratory viral coinfection was detected on admission for 101/153 (66.0%) children using extended respiratory pathogen polymerase chain reaction</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Sep</publication><modification>2025-04-19T14:50:08.588Z</modification><creation>2025-04-19T14:50:08.588Z</creation></dates><accession>S-EPMC11319078</accession><cross_references><pubmed>38900036</pubmed><doi>10.1097/INF.0000000000004418</doi></cross_references></HashMap>